BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.53
+0.18 (2.16%)
At close: Aug 13, 2025, 4:00 PM
8.49
-0.04 (-0.47%)
After-hours: Aug 13, 2025, 5:54 PM EDT
BioCryst Pharmaceuticals Employees
BioCryst Pharmaceuticals had 580 employees as of December 31, 2024. The number of employees increased by 44 or 8.21% compared to the previous year.
Employees
580
Change (1Y)
44
Growth (1Y)
8.21%
Revenue / Employee
$961,217
Profits / Employee
-$61,571
Market Cap
1.79B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCRX News
- 2 days ago - BioCryst Announces Departure of Dr. Helen Thackray - GlobeNewsWire
- 7 days ago - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - BioCryst Pharmaceuticals, Inc. (BCRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 13 days ago - BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December - GlobeNewsWire
- 23 days ago - BioCryst to Report Second Quarter 2025 Financial Results on August 4 - GlobeNewsWire
- 5 weeks ago - BioCryst to Highlight Patient-focused Research at the 2025 US HAEA National Summit - GlobeNewsWire
- 5 weeks ago - BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development - GlobeNewsWire